Vaccine

Article	Citations
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?	801
Evidence for antibody as a protective correlate for COVID-19 vaccines	740
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic	475
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	468
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	387
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	358
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	351
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional surv	319
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	258
mRNA vaccines manufacturing: Challenges and bottlenecks	227
Human monkeypox – After 40 years, an unintended consequence of smallpox eradication	206
Myocarditis following COVID-19 mRNA vaccination	202
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	187
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	180
Vaccine hesitancy and perceived behavioral control: A meta-analysis	179
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	170
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	147
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	144
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data	141
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	138
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	137
The disease burden of influenza beyond respiratory illness	136
Individual preferences for COVID-19 vaccination in China	135
COVID-19 vaccine intentions in the United States, a social-ecological framework	129
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	121

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	117
Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US	117
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	116
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	116
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	113
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	113
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	110
Towards a population-based threshold of protection for COVID-19 vaccines	108
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	107
Arboviruses: A global public health threat	106
The demand for a COVID-19 vaccine in Ecuador	105
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	103
Contingent assessment of the COVID-19 vaccine	102
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	101
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	101
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines	100
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	96
Timing of COVID-19 vaccine approval and endorsement by public figures	96
Preferences for a COVID-19 vaccine in Australia	95
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	88
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	87
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	84
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	84
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	83
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	83
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	81
Christian nationalism and COVID-19 vaccine hesitancy and uptake	79
COVID-19 vaccine – Long term immune decline and breakthrough infections	78
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	78
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	76
Vaccination against coronaviruses in domestic animals	76
Influenza immunization and COVID-19	74
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	73
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	72
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	71
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	70
The need for inclusion of pregnant women in COVID-19 vaccine trials	69
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	67
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis	66
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	66
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake	66
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement	65
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey	65
Understanding immunosenescence and its impact on vaccination of older adults	64
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates	64
Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey	64
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	63
Global production capacity of seasonal and pandemic influenza vaccines in 2019	63
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil	63
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis	63

Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates	63
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research	62
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	62
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines	62
Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries	60
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access	60
Extraordinary diseases require extraordinary solutions	59
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy	59
The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident	58
Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality	57
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK	57
Low COVID-19 vaccine hesitancy in Brazil	57
Parental plans to vaccinate children for COVID-19 in New York city	57
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment	56
Optimal planning of the COVID-19 vaccine supply chain	56
Barriers and drivers to adult vaccination among family physicians – Insights for tailoring the immunization program in Germany	55
Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes	55
Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study	53
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications	52
Global vaccine action plan lessons learned I: Recommendations for the next decade	52
Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization	52
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis	52
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general	51
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety	50
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	50
Importance of COVID-19 vaccine efficacy in older age groups	50
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment	50
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action	49
Willingness to pay and financing preferences for COVID-19 vaccination in China	49
Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply	49
The relationship between parental source of information and knowledge about measles / measles vaccine and vaccine hesitancy	49
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students	48
Planning for COVID-19 vaccines safety surveillance	48
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020	48
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies	48
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse	48
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries	48
Persuasive messaging to increase COVID-19 vaccine uptake intentions	47
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019	47
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults	47
Global assessment of national mandatory vaccination policies and consequences of non-compliance	47
Healthcare Workers’ (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis	46
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	45
Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey	45
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore	45
Ethics of a partially effective dengue vaccine: Lessons from the Philippines	45
Influence of rapid COVID-19 vaccine development on vaccine hesitancy	44
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults	44
Interpreting vaccine efficacy trial results for infection and transmission	44
Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity	44
Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection	44
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age	44
“Vaccines for pregnant women…?! Absurd” – Mapping maternal vaccination discourse and stance on social media over six months	44
Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States	43
Covid-19 vaccine immunogenicity in people living with HIV-1	43
Incidence of community-acquired pneumonia in urban China: A national population-based study	43
A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China	43
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK	42
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships	42
Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign	42
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational stu	42
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group	42
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study	41
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines	41
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates	41
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection	41
Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development	41
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents	40
The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic	40
Parental vaccine hesitancy and its association with adolescent HPV vaccination	40
Underserved population acceptance of combination influenza-COVID-19 booster vaccines	40
Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy	40
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates	40
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States	40
Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia	40
An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design	40
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis	39
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations	39
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis	39
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021	39

Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies	39
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and olde	39
Beliefs towards vaccination and trust in the scientific community in Italy	39
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial	39
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States	39
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of ag	38
Henoch-Schönlein purpura presenting post COVID-19 vaccination	38
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout	37
Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UA	37
Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake	37
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality	37
Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework	37
A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations	37
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86	36
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform	36
The Health Belief Model in predicting healthcare workers' intention for influenza vaccine uptake in Jordan	36
A systematic review of communication interventions for countering vaccine misinformation	35
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic	35
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism	35
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial	35
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analys	35
The development of COVID-19 vaccines in the United States: Why and how so fast?	35
COVID-19 vaccine hesitancy among persons living in homeless shelters in France	35
Chlamydia trachomatis: Cell biology, immunology and vaccination	35
Myocarditis following COVID-19 vaccination – A case series	35
Do parasite infections interfere with immunisation? A review and meta-analysis	35
The missing season: The impacts of the COVID-19 pandemic on influenza	34
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic	34
Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii	34
Acceptance of a COVID-19 vaccine: A multifactorial consideration	34
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future	34
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis	34
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination	34
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021	34
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review	34
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents	34
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study	34
Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race	34
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	33
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines	33
Disparities in COVID-19 vaccine uptake among health care workers	33
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice	33
Misinformation and COVID-19 vaccine hesitancy	33
India’s cost-effective COVID-19 vaccine development initiatives	33
Factors limiting data quality in the expanded programme on immunization in low and middle-income countries: A scoping review	33
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study	33
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection	33
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies	33
The sources and correlates of exposure to vaccine-related (mis)information online	32
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci	32
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?	32
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG	32
A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017–18 influe	32
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020)	32
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials	32
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies	32
COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study	31
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers	31
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US)	31
Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model	31
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada	31
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study	31
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies	31
The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers’ recommendation of influenza vaccine in pregnancy	31
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial	31
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study	31
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon	31
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence	31
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine	31
A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines	31
Feasibility assessment of measles and rubella eradication	30
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes	30
The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome	30
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials	30
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162	30
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities	30
DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial	29
Parental attitudes towards mandatory vaccination; a systematic review	29
Social amplification of risk and “probable vaccine damage”: A typology of vaccination beliefs in 28 European countries	29
Spread of vaccine hesitancy in France: What about YouTube™?	29
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination	29
Continuity of routine immunization programs in Canada during the COVID-19 pandemic	29
Influenza vaccination in the time of COVID-19: A national U.S. survey of adults	29
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand	29
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?	29
Could live attenuated vaccines better control COVID-19?	29
Dementia risk following influenza vaccination in a large veteran cohort	28
COVID-19 vaccination coverage and intent among women aged 18–49 years by pregnancy status, United States, April–November 2021	28
Understanding the messages and motivation of vaccine hesitant or refusing social media influencers	28
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy	28
“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic	28
Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic	28
Imperfect messengers? An analysis of vaccine confidence among primary care physicians	28
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis	28
The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring	28